Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
2017-01-01 Sandborn, Wj; Su, Cy; Sands, Be; D'Haens, Gr; Vermeire, S; Schreiber, S; Danese, S; Feagan, Bg; Reinisch, W; Niezychowski, W; Friedman, G; Lawendy, N; Yu, Dh; Woodworth, D; Mukherjee, A; Zhang, Hy; Healey, P; Panes, J
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation
2015-01-01 Genua, M.; D'Alessio, S.; Cibella, J.; Gandelli, A.; Sala, E.; Correale, C.; Spinelli, A.; Arena, V.; Malesci, A.; Rutella, S.; Ploplis, V. A.; Vetrano, S.; Danese, S.
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis
2009-01-01 Scaldaferri, F.; Vetrano, S.; Sans, M.; Arena, V.; Straface, G.; Stigliano, E.; Sturm, A.; Malesci, A.; Panes, J.; Yla-Herttuala, S.; Fiocchi, C.; Danese, S.
The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper
2014-01-01 Fiorino, G; Girolomoni, G; Lapadula, G; Orlando, A; Danese, S; Olivieri, I
Preventing Collateral Damage in Crohn's Disease: The L,mann Index
2016-01-01 Fiorino, G; Bonifacio, C; Peyrin-Biroulet, L; Danese, S
Targeting the gut layers in Crohn's disease: mucosal or transmural healing?
2020-01-01 Zacharopoulou, Eirini; Craviotto, Vincenzo; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Gilardi, Daniela; Peyrin-Biroulet, Laurent; Danese, Silvio; Allocca, Mariangela
Ustekinumab for treating ulcerative colitis: an expert opinion
2020-01-01 Biancone, Livia; Ardizzone, Sandro; Armuzzi, Alessandro; Castiglione, Fabiana; D'Incà, Renata; Danese, Silvio; Daperno, Marco; Gionchetti, Paolo; Rizzello, Fernando; Scribano, Maria Lia; Vecchi, Maurizio; Orlando, Ambrogio
Influence of Helicobacter pylori infection on metalloproteinases expression in gastric mucosa
2002-01-01 Papa, A; Danese, S; Ricci, R; Covino, M; Maggiano, N; Rinelli, A; Grillo, A; Piscaglia, A; Vecchio, F; Gasbarrini, G; Gasbarrini, A
Familial aggregation in inflammatory bowel disease: Is it genes or environment?
2011-01-01 Nunes, T; Fiorino, G; Danese, S; Sans, M
IBD IN 2013 Enriching the therapeutic armamentarium for IBD
2014-01-01 Danese, S; Peyrin-Biroulet, L
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
2010-01-01 Vetrano, S.; Borroni, E. M.; Sarukhan, A.; Savino, B.; Bonecchi, R.; Correale, C.; Arena, V.; Fantini, M.; Roncalli, M.; Malesci, A.; Mantovani, A.; Locati, M.; Danese, S.
Adalimumab in active ulcerative colitis: A "real-life" observational study
2013-01-01 Armuzzi, A; Biancone, L; Daperno, M; Coli, A; Pugliese, D; Annese, V; Aratari, A; Ardizzone, S; Balestrieri, P; Bossa, F; Cappello, M; Castiglione, F; Cicala, M; Danese, S; D'Inca, R; Dulbecco, P; Feliciangeli, G; Fries, W; Genise, S; Gionchetti, P; Gozzi, S; Kohn, A; Lorenzetti, R; Milla, M; Onali, S; Orlando, A; Papparella, Lg; Renna, S; Ricci, C; Rizzello, F; Sostegni, R; Guidi, L; Papi, C
Tolerogenic dendritic cells: cytokine modulation comes of age
2006-01-01 Rutella, S; Danese, S; Leone, G
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease
2010-01-01 Fiorino, G.; Correale, C.; Fries, W.; Repici, A.; Malesci, A.; Danese, S.
VEGF in inflammatory bowel disease: A master regulator of mucosal immune-driven angiogenesis
2008-01-01 Danese, S
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease
2015-01-01 Fiorino, G.; Bonifacio, C.; Allocca, M.; Repici, A.; Balzarini, L.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S.
Evolving therapeutic goals in ulcerative colitis: towards disease clearance
2020-01-01 Danese, S; Roda, G; Peyrin-Biroulet, L
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis
2017-01-01 Van Welden, S; De Vos, M; Wielockx, B; Tavernier, Sj; Dullaers, M; Neyt, S; Descamps, B; Devisscher, L; Devriese, S; Van Den Bossche, L; Holvoet, T; Baeyens, A; Correale, C; D'Alessio, S; Vanhove, C; De Vos, F; Verhasselt, B; Breier, G; Lambrecht, Bn; Janssens, S; Carmeliet, P; Danese, S; Elewaut, D; Laukens, D; Hindryckx, P
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer
2019-01-01 Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico
Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
2019-01-01 Lovisa, S; Genovese, G; Danese, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis | 1-gen-2017 | Sandborn, Wj; Su, Cy; Sands, Be; D'Haens, Gr; Vermeire, S; Schreiber, S; Danese, S; Feagan, Bg; Reinisch, W; Niezychowski, W; Friedman, G; Lawendy, N; Yu, Dh; Woodworth, D; Mukherjee, A; Zhang, Hy; Healey, P; Panes, J | |
| The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation | 1-gen-2015 | Genua, M.; D'Alessio, S.; Cibella, J.; Gandelli, A.; Sala, E.; Correale, C.; Spinelli, A.; Arena, V.; Malesci, A.; Rutella, S.; Ploplis, V. A.; Vetrano, S.; Danese, S. | |
| VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis | 1-gen-2009 | Scaldaferri, F.; Vetrano, S.; Sans, M.; Arena, V.; Straface, G.; Stigliano, E.; Sturm, A.; Malesci, A.; Panes, J.; Yla-Herttuala, S.; Fiocchi, C.; Danese, S. | |
| The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper | 1-gen-2014 | Fiorino, G; Girolomoni, G; Lapadula, G; Orlando, A; Danese, S; Olivieri, I | |
| Preventing Collateral Damage in Crohn's Disease: The L,mann Index | 1-gen-2016 | Fiorino, G; Bonifacio, C; Peyrin-Biroulet, L; Danese, S | |
| Targeting the gut layers in Crohn's disease: mucosal or transmural healing? | 1-gen-2020 | Zacharopoulou, Eirini; Craviotto, Vincenzo; Fiorino, Gionata; Furfaro, Federica; Zilli, Alessandra; Gilardi, Daniela; Peyrin-Biroulet, Laurent; Danese, Silvio; Allocca, Mariangela | |
| Ustekinumab for treating ulcerative colitis: an expert opinion | 1-gen-2020 | Biancone, Livia; Ardizzone, Sandro; Armuzzi, Alessandro; Castiglione, Fabiana; D'Incà, Renata; Danese, Silvio; Daperno, Marco; Gionchetti, Paolo; Rizzello, Fernando; Scribano, Maria Lia; Vecchi, Maurizio; Orlando, Ambrogio | |
| Influence of Helicobacter pylori infection on metalloproteinases expression in gastric mucosa | 1-gen-2002 | Papa, A; Danese, S; Ricci, R; Covino, M; Maggiano, N; Rinelli, A; Grillo, A; Piscaglia, A; Vecchio, F; Gasbarrini, G; Gasbarrini, A | |
| Familial aggregation in inflammatory bowel disease: Is it genes or environment? | 1-gen-2011 | Nunes, T; Fiorino, G; Danese, S; Sans, M | |
| IBD IN 2013 Enriching the therapeutic armamentarium for IBD | 1-gen-2014 | Danese, S; Peyrin-Biroulet, L | |
| The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 | 1-gen-2010 | Vetrano, S.; Borroni, E. M.; Sarukhan, A.; Savino, B.; Bonecchi, R.; Correale, C.; Arena, V.; Fantini, M.; Roncalli, M.; Malesci, A.; Mantovani, A.; Locati, M.; Danese, S. | |
| Adalimumab in active ulcerative colitis: A "real-life" observational study | 1-gen-2013 | Armuzzi, A; Biancone, L; Daperno, M; Coli, A; Pugliese, D; Annese, V; Aratari, A; Ardizzone, S; Balestrieri, P; Bossa, F; Cappello, M; Castiglione, F; Cicala, M; Danese, S; D'Inca, R; Dulbecco, P; Feliciangeli, G; Fries, W; Genise, S; Gionchetti, P; Gozzi, S; Kohn, A; Lorenzetti, R; Milla, M; Onali, S; Orlando, A; Papparella, Lg; Renna, S; Ricci, C; Rizzello, F; Sostegni, R; Guidi, L; Papi, C | |
| Tolerogenic dendritic cells: cytokine modulation comes of age | 1-gen-2006 | Rutella, S; Danese, S; Leone, G | |
| Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease | 1-gen-2010 | Fiorino, G.; Correale, C.; Fries, W.; Repici, A.; Malesci, A.; Danese, S. | |
| VEGF in inflammatory bowel disease: A master regulator of mucosal immune-driven angiogenesis | 1-gen-2008 | Danese, S | |
| Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease | 1-gen-2015 | Fiorino, G.; Bonifacio, C.; Allocca, M.; Repici, A.; Balzarini, L.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S. | |
| Evolving therapeutic goals in ulcerative colitis: towards disease clearance | 1-gen-2020 | Danese, S; Roda, G; Peyrin-Biroulet, L | |
| Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis | 1-gen-2017 | Van Welden, S; De Vos, M; Wielockx, B; Tavernier, Sj; Dullaers, M; Neyt, S; Descamps, B; Devisscher, L; Devriese, S; Van Den Bossche, L; Holvoet, T; Baeyens, A; Correale, C; D'Alessio, S; Vanhove, C; De Vos, F; Verhasselt, B; Breier, G; Lambrecht, Bn; Janssens, S; Carmeliet, P; Danese, S; Elewaut, D; Laukens, D; Hindryckx, P | |
| NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer | 1-gen-2019 | Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico | |
| Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease | 1-gen-2019 | Lovisa, S; Genovese, G; Danese, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1